Acute Care
The COVID-19 pandemic has increased demand, and North America is projected to continue its global market dominance.
Proper prevention, treatment and management can help to mitigate the trauma and stress of being on the front lines.
AHIP releases new data suggesting COVID-19 treatments could cost up to $546.6 billion - less than previous estimates.
Younger patients are driving this decline, as the biggest dip was seen among children younger than 14.
naviHealth will continue to work with its clients and members as a standalone entity aligned with OptumHealth.
Anecdotal evidence suggests the psychological toll of being on the front lines may lead to an uptick in mental health disorders.
Reports of severe illness among children are mounting, requiring more urgent research into susceptibility and possible treatments.
While it hasn't yet been tested in humans, its ability to target multiple coronaviruses shows early promise.
Many have but back on healthcare visits or are planning to do so, and a substantial number are considering curbing medication spending.
Hydroxychloroquine can reduce inflammation, pain and swelling, but mild to moderate COVID patients showed more adverse events when treated with it.